Postmenopausal status and early menopause as independent risk factors for cardiovascular disease: a meta-analysis
- PMID: 16645540
- DOI: 10.1097/01.gme.0000218683.97338.ea
Postmenopausal status and early menopause as independent risk factors for cardiovascular disease: a meta-analysis
Abstract
Objective: Loss of ovarian function and subsequent deficiency of endogenous estrogens is suggested to enhance cardiovascular disease risk and related death after menopause. The aim was to obtain valid estimates of the cardiovascular disease risk associated with postmenopausal status and early menopause.
Design: A literature search of observational studies was performed using PubMed and EMBASE (1966 to May 1, 2004). Eighteen studies on postmenopausal status and age at menopause in relation to cardiovascular disease were selected. Six studies investigated menopausal status, nine studies investigated menopausal age, and three studied both. General variance-based methods were used to pool relative risk estimates and corresponding 95% confidence intervals. Stratification was performed for study design, type of menopause, outcome, and adjustment for age and smoking.
Results: The pooled relative risk estimate for postmenopausal versus premenopausal status and cardiovascular disease was 1.36 (95% CI, 1.15-1.60). In the stratified analysis, the pooled effect was 0.96 (95% CI, 0.77-1.21) after controlling for age and smoking. The pooled effect of bilateral oophorectomy on cardiovascular disease was 2.62 (95% CI, 2.05-3.35). For early menopause and cardiovascular disease, with the menopausal age category containing 50 years as a reference, the pooled relative risk estimate was 1.25 (95% CI, 1.15-1.35). In the stratified analysis, the pooled effect was 1.38 (95% CI, 1.21-1.58) after controlling for age and smoking. The pooled effect of bilateral oophorectomy on cardiovascular disease was 4.55 (95% CI, 2.56-8.01).
Conclusions: Overall, there was no convincing relationship between postmenopausal status and cardiovascular disease. However, there was a modest effect of early menopause on cardiovascular disease. The effect was more pronounced for women with an artificial menopause than for women with a natural menopause.
Similar articles
-
Heart disease risk determines menopausal age rather than the reverse.J Am Coll Cardiol. 2006 May 16;47(10):1976-83. doi: 10.1016/j.jacc.2005.12.066. Epub 2006 Apr 24. J Am Coll Cardiol. 2006. PMID: 16697313
-
The effect of menopause on disease activity in systemic lupus erythematosus.J Rheumatol. 2006 Nov;33(11):2192-8. Epub 2006 Sep 15. J Rheumatol. 2006. PMID: 16981295
-
Postmenopausal status according to years since menopause as an independent risk factor for the metabolic syndrome.Menopause. 2008 May-Jun;15(3):524-9. doi: 10.1097/gme.0b013e3181559860. Menopause. 2008. PMID: 18467953
-
Postmenopausal hormone therapy and the risk of cardiovascular disease.J Cardiovasc Med (Hagerstown). 2009 Apr;10(4):303-9. doi: 10.2459/JCM.0b013e328324991c. J Cardiovasc Med (Hagerstown). 2009. PMID: 19430340 Review.
-
Prevention of cardiovascular events in early menopause: a possible role for hormone replacement therapy.Int J Cardiol. 2008 Nov 12;130(2):140-6. doi: 10.1016/j.ijcard.2008.03.051. Epub 2008 Jul 9. Int J Cardiol. 2008. PMID: 18617278 Review.
Cited by
-
Basic knowledge for counseling patients undergoing risk-reducing salpingo-oophorectomy.Obstet Gynecol Sci. 2024 Jul;67(4):343-355. doi: 10.5468/ogs.24054. Epub 2024 May 31. Obstet Gynecol Sci. 2024. PMID: 38817104 Free PMC article.
-
Summary of the 2023 Thai Menopause Society Clinical Practice Guideline on Menopausal Hormone Therapy.J Menopausal Med. 2024 Apr;30(1):24-36. doi: 10.6118/jmm.24006. J Menopausal Med. 2024. PMID: 38714491 Free PMC article. Review.
-
Aromatase Inhibitors and Plasma Lipid Changes in Postmenopausal Women with Breast Cancer: A Systematic Review and Meta-Analysis.J Clin Med. 2024 Mar 21;13(6):1818. doi: 10.3390/jcm13061818. J Clin Med. 2024. PMID: 38542042 Free PMC article. Review.
-
Prevalence of Sex-Specific Cardiovascular Disease Risk Factors, Medical Risk, and Engagement in Health-Promoting Behaviours in Premenopausal Females.CJC Open. 2023 Nov 7;6(2Part B):301-313. doi: 10.1016/j.cjco.2023.11.003. eCollection 2024 Feb. CJC Open. 2023. PMID: 38487073 Free PMC article.
-
PGT-M for Premature Ovarian Failure Related to CGG Repeat Expansion of the FMR1 Gene.Genes (Basel). 2023 Dec 19;15(1):6. doi: 10.3390/genes15010006. Genes (Basel). 2023. PMID: 38275588 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical